Zymeworks Inc.
N/A
USD
N/A
N/A
...
Chart
Financials
Description
ZYME Company Description
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated product candidates. Its clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
ZYME Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view ZYME Smart Score
Score Breakdown
ZYME Company Description
Show More
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated product candidates. Its clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. Show Less
All
Government
Consumer Interest
SEC Filings
ESG/Other
Recent trades of ZYME by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by ZYME's directors and management
Government lobbying spending instances
U.S. Patents
New patents grants
Government Contracts
Federal grants, loans, and purchases
Twitter
Followers on ZYME's company Twitter account
WallStreetBets
Number of mentions of ZYME in WallStreetBets Daily Discussion
ZYME News
Recent insights relating to ZYME
CNBC Recommendations
Recent picks made for ZYME stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in ZYME
Corporate Flights
Flights by private jets registered to ZYME
Our Analysis